These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 30615457

  • 1. Tocopherol Emulsions as Functional Autoantigen Delivery Vehicles Evoke Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis.
    Griffin JD, Christopher MA, Thati S, Salash JR, Pressnall MM, Weerasekara DB, Lunte SM, Berkland CJ.
    Mol Pharm; 2019 Feb 04; 16(2):607-617. PubMed ID: 30615457
    [Abstract] [Full Text] [Related]

  • 2. Co-delivery of autoantigen and dexamethasone in incomplete Freund's adjuvant ameliorates experimental autoimmune encephalomyelitis.
    Northrup L, Griffin JD, Christopher MA, Antunez LR, Hartwell BL, Pickens CJ, Berkland C.
    J Control Release; 2017 Nov 28; 266():156-165. PubMed ID: 28963036
    [Abstract] [Full Text] [Related]

  • 3. Co-delivery of autoantigen and b7 pathway modulators suppresses experimental autoimmune encephalomyelitis.
    Northrup L, Sestak JO, Sullivan BP, Thati S, Hartwell BL, Siahaan TJ, Vines CM, Berkland C.
    AAPS J; 2014 Nov 28; 16(6):1204-13. PubMed ID: 25297853
    [Abstract] [Full Text] [Related]

  • 4. Autoantigen Tetramer Silences Autoreactive B Cell Populations.
    Christopher MA, Johnson SN, Griffin JD, Berkland CJ.
    Mol Pharm; 2020 Nov 02; 17(11):4201-4211. PubMed ID: 32903002
    [Abstract] [Full Text] [Related]

  • 5. Pulmonary Administration of Soluble Antigen Arrays Is Superior to Antigen in Treatment of Experimental Autoimmune Encephalomyelitis.
    Kuehl C, Thati S, Sullivan B, Sestak J, Thompson M, Siahaan T, Berkland C.
    J Pharm Sci; 2017 Nov 02; 106(11):3293-3302. PubMed ID: 28625726
    [Abstract] [Full Text] [Related]

  • 6. Combination of apoptotic T cell induction and self-peptide administration for therapy of experimental autoimmune encephalomyelitis.
    Kasagi S, Wang D, Zhang P, Zanvit P, Chen H, Zhang D, Li J, Che L, Maruyama T, Nakatsukasa H, Wu R, Jin W, Sun L, Chen W.
    EBioMedicine; 2019 Jun 02; 44():50-59. PubMed ID: 31097410
    [Abstract] [Full Text] [Related]

  • 7. Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis.
    Sestak JO, Fakhari A, Badawi AH, Siahaan TJ, Berkland C.
    AAPS J; 2014 Nov 02; 16(6):1185-93. PubMed ID: 25193268
    [Abstract] [Full Text] [Related]

  • 8. Soluble antigen arrays disarm antigen-specific B cells to promote lasting immune tolerance in experimental autoimmune encephalomyelitis.
    Hartwell BL, Pickens CJ, Leon M, Northrup L, Christopher MA, Griffin JD, Martinez-Becerra F, Berkland C.
    J Autoimmun; 2018 Sep 02; 93():76-88. PubMed ID: 30007842
    [Abstract] [Full Text] [Related]

  • 9. Antigen-specific immune decoys intercept and exhaust autoimmunity to prevent disease.
    Griffin JD, Song JY, Huang A, Sedlacek AR, Flannagan KL, Berkland CJ.
    Biomaterials; 2019 Nov 02; 222():119440. PubMed ID: 31450159
    [Abstract] [Full Text] [Related]

  • 10. Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
    Kleist C, Mohr E, Gaikwad S, Dittmar L, Kuerten S, Platten M, Mier W, Schmitt M, Opelz G, Terness P.
    J Transl Med; 2016 May 01; 14(1):99. PubMed ID: 27131971
    [Abstract] [Full Text] [Related]

  • 11. Antigen-Drug Conjugates as a Novel Therapeutic Class for the Treatment of Antigen-Specific Autoimmune Disorders.
    Pickens CJ, Christopher MA, Leon MA, Pressnall MM, Johnson SN, Thati S, Sullivan BP, Berkland C.
    Mol Pharm; 2019 Jun 03; 16(6):2452-2461. PubMed ID: 31083955
    [Abstract] [Full Text] [Related]

  • 12. Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis: a comparison between oral and peripheral tolerance.
    Kennedy KJ, Smith WS, Miller SD, Karpus WJ.
    J Immunol; 1997 Jul 15; 159(2):1036-44. PubMed ID: 9218627
    [Abstract] [Full Text] [Related]

  • 13. Modulation of MS-like disease by a multi epitope protein is mediated by induction of CD11c+CD11b+Gr1+ myeloid-derived dendritic cells.
    Kaushansky N, Kaminitz A, Allouche-Arnon H, Ben-Nun A.
    J Neuroimmunol; 2019 Aug 15; 333():476953. PubMed ID: 31108399
    [Abstract] [Full Text] [Related]

  • 14. Targeting DEC-205-DCIR2+ dendritic cells promotes immunological tolerance in proteolipid protein-induced experimental autoimmune encephalomyelitis.
    Tabansky I, Keskin DB, Watts D, Petzold C, Funaro M, Sands W, Wright P, Yunis EJ, Najjar S, Diamond B, Cao Y, Mooney D, Kretschmer K, Stern JNH.
    Mol Med; 2018 May 03; 24(1):17. PubMed ID: 30134798
    [Abstract] [Full Text] [Related]

  • 15. The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy.
    Taylor AW, Kitaichi N.
    Brain Behav Immun; 2008 Jul 03; 22(5):639-46. PubMed ID: 18171609
    [Abstract] [Full Text] [Related]

  • 16. Ethanol extract of Glycyrrhizae Radix modulates the responses of antigen-specific splenocytes in experimental autoimmune encephalomyelitis.
    Yang EJ, Song IS, Song KS.
    Phytomedicine; 2019 Feb 15; 54():56-65. PubMed ID: 30668383
    [Abstract] [Full Text] [Related]

  • 17. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL, Neville KL, Nikcevich KM, Eagar TN, Bluestone JA, Miller SD.
    J Immunol; 2000 Jan 15; 164(2):670-8. PubMed ID: 10623809
    [Abstract] [Full Text] [Related]

  • 18. Screening Immunomodulators To Skew the Antigen-Specific Autoimmune Response.
    Northrup L, Sullivan BP, Hartwell BL, Garza A, Berkland C.
    Mol Pharm; 2017 Jan 03; 14(1):66-80. PubMed ID: 28043135
    [Abstract] [Full Text] [Related]

  • 19. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes.
    Vandenbark AA, Vainiene M, Ariail K, Miller SD, Offner H.
    J Neurosci Res; 1996 Aug 15; 45(4):430-8. PubMed ID: 8872903
    [Abstract] [Full Text] [Related]

  • 20. Adjuvants as Delivery Systems in Antigen-Specific Immunotherapies.
    Antúnez LR, Pressnall MM, Berkland CJ.
    J Pharm Sci; 2019 Dec 15; 108(12):3831-3841. PubMed ID: 31526814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.